MicroRNAs in cardiovascular ageing

Timon Seeger, Reinier A. Boon

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

MicroRNAs (miRs) have emerged as potent regulators of pathways in physiological and disease contexts. This review focuses on the role of miRs in ageing of the cardiovascular system. Several miRs have been described to be regulated during ageing and some of these miRs are involved in the regulation of ageing-related processes. We discuss the roles of miR-34, miR-217 and miR-29, which are induced during ageing in the vasculature. The roles of miR-34, miR-29 (age-induced) and miR-18/19, which are decreased during ageing in the heart, are discussed as well. Furthermore, numerous miRs that play a role in diseases associated with ageing, like diabetes, atherosclerosis, hypertension, cardiac hypertrophy and atrial fibrillation, are also briefly discussed. miRs also serve as circulating biomarkers for cardiovascular ageing or ageing-associated diseases. Finally, pharmacological modulation of ageing-related miRs might become a promising strategy to combat cardiovascular ageing in a clinical setting.

Original languageEnglish
Pages (from-to)2085-2094
Number of pages10
JournalJournal of Physiology
Volume594
Issue number8
DOIs
Publication statusPublished - 15 Apr 2016

Cite this

Seeger, Timon ; Boon, Reinier A. / MicroRNAs in cardiovascular ageing. In: Journal of Physiology. 2016 ; Vol. 594, No. 8. pp. 2085-2094.
@article{2a1e16ce86774dc6ac1a0223be59d30f,
title = "MicroRNAs in cardiovascular ageing",
abstract = "MicroRNAs (miRs) have emerged as potent regulators of pathways in physiological and disease contexts. This review focuses on the role of miRs in ageing of the cardiovascular system. Several miRs have been described to be regulated during ageing and some of these miRs are involved in the regulation of ageing-related processes. We discuss the roles of miR-34, miR-217 and miR-29, which are induced during ageing in the vasculature. The roles of miR-34, miR-29 (age-induced) and miR-18/19, which are decreased during ageing in the heart, are discussed as well. Furthermore, numerous miRs that play a role in diseases associated with ageing, like diabetes, atherosclerosis, hypertension, cardiac hypertrophy and atrial fibrillation, are also briefly discussed. miRs also serve as circulating biomarkers for cardiovascular ageing or ageing-associated diseases. Finally, pharmacological modulation of ageing-related miRs might become a promising strategy to combat cardiovascular ageing in a clinical setting.",
author = "Timon Seeger and Boon, {Reinier A.}",
year = "2016",
month = "4",
day = "15",
doi = "10.1113/JP270557",
language = "English",
volume = "594",
pages = "2085--2094",
journal = "Journal of Physiology - London",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "8",

}

MicroRNAs in cardiovascular ageing. / Seeger, Timon; Boon, Reinier A.

In: Journal of Physiology, Vol. 594, No. 8, 15.04.2016, p. 2085-2094.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - MicroRNAs in cardiovascular ageing

AU - Seeger, Timon

AU - Boon, Reinier A.

PY - 2016/4/15

Y1 - 2016/4/15

N2 - MicroRNAs (miRs) have emerged as potent regulators of pathways in physiological and disease contexts. This review focuses on the role of miRs in ageing of the cardiovascular system. Several miRs have been described to be regulated during ageing and some of these miRs are involved in the regulation of ageing-related processes. We discuss the roles of miR-34, miR-217 and miR-29, which are induced during ageing in the vasculature. The roles of miR-34, miR-29 (age-induced) and miR-18/19, which are decreased during ageing in the heart, are discussed as well. Furthermore, numerous miRs that play a role in diseases associated with ageing, like diabetes, atherosclerosis, hypertension, cardiac hypertrophy and atrial fibrillation, are also briefly discussed. miRs also serve as circulating biomarkers for cardiovascular ageing or ageing-associated diseases. Finally, pharmacological modulation of ageing-related miRs might become a promising strategy to combat cardiovascular ageing in a clinical setting.

AB - MicroRNAs (miRs) have emerged as potent regulators of pathways in physiological and disease contexts. This review focuses on the role of miRs in ageing of the cardiovascular system. Several miRs have been described to be regulated during ageing and some of these miRs are involved in the regulation of ageing-related processes. We discuss the roles of miR-34, miR-217 and miR-29, which are induced during ageing in the vasculature. The roles of miR-34, miR-29 (age-induced) and miR-18/19, which are decreased during ageing in the heart, are discussed as well. Furthermore, numerous miRs that play a role in diseases associated with ageing, like diabetes, atherosclerosis, hypertension, cardiac hypertrophy and atrial fibrillation, are also briefly discussed. miRs also serve as circulating biomarkers for cardiovascular ageing or ageing-associated diseases. Finally, pharmacological modulation of ageing-related miRs might become a promising strategy to combat cardiovascular ageing in a clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=84934783609&partnerID=8YFLogxK

U2 - 10.1113/JP270557

DO - 10.1113/JP270557

M3 - Review article

VL - 594

SP - 2085

EP - 2094

JO - Journal of Physiology - London

JF - Journal of Physiology - London

SN - 0022-3751

IS - 8

ER -